Publications by authors named "Aizenstein B"

Article Synopsis
  • Akt plays a crucial role in cellular growth and survival, and its mutations are linked to cancer, making it a target for drug development.
  • Researchers observed that inhibitors targeting Akt can unintentionally cause hyperphosphorylation of the kinase itself.
  • To study this, they developed a strategy to replace the native Akt with a mutant version that can bind a specific engineered inhibitor, leading to the creation of a selective compound called PrINZ.
View Article and Find Full Text PDF

PI3Kdelta and PI3Kgamma regulate immune cell signaling, while the related PI3Kalpha and PI3Kbeta regulate cell survival and metabolism. Selective inhibitors of PI3Kdelta/gamma represent a potential class of anti-inflammatory agents lacking the antiproliferative effects associated with PI3Kalpha/beta inhibition. Here we report the discovery of PI3Kdelta/gamma inhibitors that display up to 1000-fold selectivity over PI3Kalpha/beta and evaluate these compounds in a high-content inflammation assay using mixtures of primary human cells.

View Article and Find Full Text PDF

Background: Injuries in kidney transplant is currently diagnosed by needle biopsy. A noninvasive test that sensitively detects these injuries would benefit the patients.

Methods: Urine samples were collected from healthy controls and kidney transplant recipients.

View Article and Find Full Text PDF
Article Synopsis
  • The kinase Akt is crucial for regulating growth factor signals, making it a key target for cancer drugs.
  • A-443654 is an ATP-competitive inhibitor of Akt that surprisingly leads to hyperphosphorylation of Akt at important regulatory sites.
  • Research shows this hyperphosphorylation is caused by the inhibitor binding directly to Akt's ATP site, rather than disrupting feedback mechanisms, highlighting new understandings of Akt regulation and the function of Akt inhibitors.
View Article and Find Full Text PDF

The clinical success of multitargeted kinase inhibitors has stimulated efforts to identify promiscuous drugs with optimal selectivity profiles. It remains unclear to what extent such drugs can be rationally designed, particularly for combinations of targets that are structurally divergent. Here we report the systematic discovery of molecules that potently inhibit both tyrosine kinases and phosphatidylinositol-3-OH kinases, two protein families that are among the most intensely pursued cancer drug targets.

View Article and Find Full Text PDF

A noninvasive urinary test that diagnoses acute renal allograft dysfunction would benefit renal transplant patients. We aimed to develop a rapid urinary diagnostic test by detecting chemokines. Seventy-three patients with renal allograft dysfunction prompting biopsy and 26 patients with stable graft function were recruited.

View Article and Find Full Text PDF

The cytochrome p450 (CYP) superfamily comprises enzymes that play an essential role in the transformation of medically relevant compounds. Accurate genotyping of polymorphisms in members of this family is drawing increasing interest because certain allelic variants may result in either loss of efficacy or toxic accumulation of therapeutic agents. Debrisoquine 4-hydroxylase, or CYP2D6, is among the most widely studied of the CYPs.

View Article and Find Full Text PDF

Humans infected with the dimorphic fungus Blastomyces dermatitidis develop strong T-lymphocyte responses to WI-1, an immunodominant antigen that has been shown to elicit protective immunity in mice. In the present study, the T-cell epitopes of WI-1 and human leukocyte antigen (HLA) restricting elements that display them were investigated. Peripheral blood mononuclear cells (PBMC) from 37 patients with a confirmed history of blastomycosis were tested for a response to WI-1 in primary proliferation assays; PBMC from 35 (95%) responded.

View Article and Find Full Text PDF

African strains of Blastomyces dermatitidis differ from North American strains in their growth, morphology, and clinical disease phenotype. In addition, two serotypes, designated 1 and 2, have been described. We investigated African strains of B.

View Article and Find Full Text PDF

The characterization of B cell epitopes on the trypanosome variant surface glycoprotein (VSG) rests on elucidation of variant specific amino acid sequences that may be exposed or buried as a result of the natural conformation of these molecules in the surface coat. Despite the fact that different VSGs have heterogeneous primary sequences and unique antigenic characteristics, recent high resolution X-ray crystallographic analyses of VSGs have revealed a conserved 3-dimensional structure common to these surface proteins [19]. We took advantage of this conserved structural conformation to help predict which variant subregions of VSG molecules may contain exposed or buried variant specific B cell epitopes.

View Article and Find Full Text PDF